Document is current

Any future updates will be listed below

A retrospective feasibility study of biweekly, reduced-dose docetaxel in Asian patients with castrate-resistant, metastatic prostate cancer

Crossref DOI link: https://doi.org/10.1186/s12894-017-0253-z

Published Online: 2017-08-22

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark